Weight Loss Drug Ads: Good or Bad?

This encore episode of Under The Influence is one of our favourites of 2026.Lately, companies have been hijacking breaking news stories to create ads.When thieves broke into the Louvre with a ladder, the ladder company quickly produced a tongue-in-cheek ad.When the Oscars read th ...  Show more

This week, it’s our annual Bookmarks episode.We read a lot of books to research this show. And this episode is dedicated to the great stories that didn’t fit into our regular season.We’ll talk about the importance of numbers in marketing, and a hilarious tale about expense report ...  Show more

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront ...  Show more

Has a name brand prescription medication ever shot to notoriety as quickly as Viagra did? Within a few months of its arrival on the market, it seems like everyone knew about the little blue pill, whether through commercials featuring celebrity spokespeople or from endless jokes o ...  Show more

News about weight-loss drugs is hard to miss. A new generation of drugs — Ozempic, Wegovy, Mounjaro, Zepbound — are on television, on billboards, and in many of our homes. There is little debate about the efficacy of the drugs for weight loss (they work, at least for most people) ...  Show more

Yes, drugs like Ozempic, Wegovy, and Mounjaro can help people lose weight, but at what cost? Dr. Sanjay Gupta explores why these drugs may not be the right fit for everyone. Learn more about your ad choices. Visit podcastchoices.com/adchoices